What happens if the EGFR allele is mutated?
EGFR (epidermal growth factor receptor) is a protein on cells that helps them grow. A mutation in the gene for EGFR can make it grow too much, which can cause cancer.
What Exon is EGFR T790M?
T790M, also known as Thr790Met, is a gatekeeper mutation of the epidermal growth factor receptor (EGFR). The mutation substitutes a threonine (T) with a methionine (M) at position 790 of exon 20, affecting the ATP binding pocket of the EGFR kinase domain.
What does it mean to have an EGFR mutation for cancer patients?
EGFR stands for epidermal growth factor receptor. It’s a protein found on healthy cells. When cancer cells test positive for EGFR, it means the gene contains a mutation and is sending faulty instructions to the cells, allowing cancer to grow and spread.
What is EGFR mutation status?
Objective. Epidermal growth factor receptor (EGFR) gene mutation status is a well-established predictor of the efficacy of EGFR tyrosine-kinase inhibitor (TKI) therapy in patients with non–small cell lung cancer.
What causes EGFR gene mutation?
An EGFR mutation occurs when there is an error in the DNA that makes up the protein. These errors are also a type of biomarker. A biomarker is a biological molecule that can be an indicator of a certain condition or disease, according to the National Cancer Institute .
How do you test for T790M mutation?
Testing for the presence of EGFR T790M as a mechanism of resistance can be performed on either ctdna from plasma or dna from tissue. A liquid biopsy analyzes small fragments of cell-free ctdna that is shed into the blood.
What is exon 20 mutation?
EGFR exon 20 insertion mutations are heterogeneous at the molecular level but can be characterized as inframe insertions or duplications of between 3 and 21 bp (corresponding to 1 to 7 amino acids) clustered between amino acid positions 762 and 774 of the EGFR protein.
How common are EGFR mutations in lung cancer?
Introduction. Activating mutations in the epidermal growth factor receptor (EGFR) gene occur in 10–20% of Caucasian and at least 50% of Asian non-small cell lung cancer (NSCLC) patients [[1], [2], [3], [4]].
How common is EGFR mutation?
Can EGFR mutation change?
Among 19% (12 of 63) of patients, EGFR mutation status changed from mutated type to wild type (9). Disappearance of activated EGFR mutation in malignant pleural effusion after treatment with chemotherapy and EGFR TKIs in a Japanese woman has also been reported by Honda et al.
